Replies to post #90275 on Avid Bioservices Inc (CDMO)

[jakedogman1]

if you were to guestimate the mos numbers, would you come up with an estimate of time from 50% to 61% for control arm and then come up with estimate for 35% to 50% for bavi arms?

[Thurly]

Especially since, according to the abstract:

Of the 121 patients randomized, no significant differences were seen in baseline characteristics (gender, age, ethnicity, ECOG or disease stage.)

So although the control arm enrolled very sick patients, so did the treatment arms.

[jbainseky]

FTM - Question

Is there data on the studies you have in you table on the disease stage of those participants? As has been noted, the recent Bavi trials showed an "abnormally" low control group MOS compared to those studies? Hopefully, at a minimum, Gerber clears up any ambiguity regarding potential bias within the study.

Thanks

JBAIN